%0 Journal Article %1 fabre2020omtx705 %A Fabre, Myriam %A Ferrer, Cristina %A Dominguez-Hormaetxe, Saioa %A Bockorny, Bruno %A Murias, Laura %A Seifert, Oliver %A Eisler, Stephan A. %A Kontermann, Roland E. %A Pfizenmaier, Klaus %A Lee, So Young %A Vivanco, Maria dM. %A Lopez-Casas, Pedro P. %A Perea, Sofia %A Abbas, Muhammad %A Richter, Wolfgang %A Simon, Laureano %A Hidalgo, Manuel %D 2020 %I American Association for Cancer Research %J Clinical Cancer Research %K %N 13 %P 3420-3430 %R 10.1158/1078-0432.CCR-19-2238 %T OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models %V 26

@article{fabre2020omtx705, added-at = {2023-08-31T15:13:58.000+0200}, affiliation = {Fabre, M (Corresponding Author), Oncomatryx Biopharma SL, Edificio 801-B,Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain. Hidalgo, M (Corresponding Author), Weill Cornell Med, Hematol & Med Oncol, 1305 York Ave,Y741,Box 403, New York, NY 10021 USA. Fabre, Myriam; Ferrer, Cristina; Dominguez-Hormaetxe, Saioa; Murias, Laura; Simon, Laureano, Oncomatryx Biopharma SL, Edificio 801-B,Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain. Bockorny, Bruno; Perea, Sofia, Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA. Seifert, Oliver; Eisler, Stephan A.; Kontermann, Roland E.; Pfizenmaier, Klaus, Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany. Lee, So Young; Vivanco, Maria dM., CIC BioGUNE, Derio, Spain. Lopez-Casas, Pedro P.; Perea, Sofia; Hidalgo, Manuel, Spanish Natl Canc Res Ctr CNIO, Gastrointestinal Canc Clin Res Unit, Madrid, Spain. Abbas, Muhammad; Richter, Wolfgang, TUBE Pharmaceut, Vienna, Austria. Hidalgo, Manuel, Weill Cornell Med Coll, New York, NY USA.}, author = {Fabre, Myriam and Ferrer, Cristina and Dominguez-Hormaetxe, Saioa and Bockorny, Bruno and Murias, Laura and Seifert, Oliver and Eisler, Stephan A. and Kontermann, Roland E. and Pfizenmaier, Klaus and Lee, So Young and Vivanco, Maria dM. and Lopez-Casas, Pedro P. and Perea, Sofia and Abbas, Muhammad and Richter, Wolfgang and Simon, Laureano and Hidalgo, Manuel}, biburl = {https://puma.ub.uni-stuttgart.de/bibtex/200976506e61e3d9e863cc6ff883ed455/puma-wartung}, doi = {10.1158/1078-0432.CCR-19-2238}, interhash = {37b6b6cda6e3c30bf427521ffde95266}, intrahash = {00976506e61e3d9e863cc6ff883ed455}, issn = {{1078-0432} and {1557-3265}}, journal = {Clinical Cancer Research}, keywords = {}, language = {eng}, number = 13, orcid-numbers = {Lopez-Casas, Pedro P./0000-0001-9866-7361}, pages = {3420-3430}, publisher = {American Association for Cancer Research}, research-areas = {Oncology}, timestamp = {2023-08-31T13:13:58.000+0200}, title = {OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models}, unique-id = {ISI:000546016400036}, volume = 26, year = 2020 }